These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9669944)

  • 1. Toward HIV eradication or remission: the tasks ahead.
    Ho DD
    Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
    Vandergeeten C; Fromentin R; Chomont N
    Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
    Finzi D; Hermankova M; Pierson T; Carruth LM; Buck C; Chaisson RE; Quinn TC; Chadwick K; Margolick J; Brookmeyer R; Gallant J; Markowitz M; Ho DD; Richman DD; Siliciano RF
    Science; 1997 Nov; 278(5341):1295-300. PubMed ID: 9360927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV survives drug onslaught by hiding out in T cells.
    Balter M
    Science; 1997 Nov; 278(5341):1227. PubMed ID: 9411749
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential role of immune modulation in the effective long-term control of HIV-1 infection.
    Rizzardi GP; Lazzarin A; Pantaleo G
    J Biol Regul Homeost Agents; 2002; 16(1):83-90. PubMed ID: 12003181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ongoing HIV dissemination during HAART.
    Grossman Z; Polis M; Feinberg MB; Grossman Z; Levi I; Jankelevich S; Yarchoan R; Boon J; de Wolf F; Lange JM; Goudsmit J; Dimitrov DS; Paul WE
    Nat Med; 1999 Oct; 5(10):1099-104. PubMed ID: 10502799
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovering from the ravages HIV.
    Cohen J
    Science; 1997 Jul; 277(5322):33. PubMed ID: 9229769
    [No Abstract]   [Full Text] [Related]  

  • 8. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
    Wong JK; Hezareh M; Günthard HF; Havlir DV; Ignacio CC; Spina CA; Richman DD
    Science; 1997 Nov; 278(5341):1291-5. PubMed ID: 9360926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of immune-modulating compounds to disrupt HIV latency.
    Remoli AL; Marsili G; Battistini A; Sgarbanti M
    Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
    Siliciano JD; Siliciano RF
    J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
    Pohlmeyer CW; Walker-Sperling VE; Blankson JN
    Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
    [No Abstract]   [Full Text] [Related]  

  • 17. A reservoir for HIV in patients on combination antiretroviral therapy.
    Siliciano RF
    Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
    Bucy RP
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-16 anti-HIV-1 therapy.
    Viglianti GA; Parada NA; Maciaszek JW; Kornfeld H; Center DM; Cruikshank WW
    Nat Med; 1997 Sep; 3(9):938. PubMed ID: 9288705
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV/AIDS eradication.
    Marsden MD; Zack JA
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4003-10. PubMed ID: 23735743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.